KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) insider Edward P. Feener sold 8,088 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $11.76, for a total value of $95,114.88. Following the sale, the insider now directly owns 72,858 shares in […]
AJOVista LLC Acquires Shares of 4,920 KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) CFO Benjamin L. Palleiko Sells 22,802 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par bought 4,174 shares of the business’s stock in a transaction on Friday, January 26th. The stock was purchased at an average cost of $12.98 per share, for a total transaction of $54,178.52. Following the transaction, the insider now owns 4,569,984 shares […]
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 67,546 shares of the business’s stock in a transaction on Monday, January 22nd. The shares were bought at an average cost of $12.55 per share, with a total value of $847,702.30. Following the completion of the acquisition, the insider now […]
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par purchased 47,700 shares of KalVista Pharmaceuticals stock in a transaction that occurred on Wednesday, January 10th. The shares were acquired at an average price of $12.67 per share, with a total value of $604,359.00. Following the acquisition, the insider now directly […]
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 69,184 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The shares were bought at an average price of $12.44 per share, with a total value of $860,648.96. Following the completion of the purchase, the […]
Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells $224,045.21 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells 22,679 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 17,605 shares of the stock in a transaction dated Wednesday, January 3rd. The stock was acquired at an average cost of $12.20 per share, with a total value of $214,781.00. Following the completion of the transaction, the insider now owns […]